Related Experiment Video
Updated: Jun 29, 2026
11:17
A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Myocardial protection in sepsis
1Division of Cardiology, University of Colorado Denver, Aurora, CO 80045, USA. Simon.Shakar@UCHSC.edu
Critical Care (London, England)
|October 3, 2008
Summary
Beta-blockers may pose risks in acute sepsis due to potential hemodynamic compromise. Adrenergic activation supports cardiovascular function in critical illness, warranting caution when using beta-blockers in septic patients.
Area of Science:
- Cardiology
- Critical Care Medicine
- Pharmacology
Background:
- Sepsis frequently causes myocardial dysfunction.
- Beta-blockers are effective for chronic heart failure by mitigating detrimental adrenergic drive.
- Acute beta-blocker use in sepsis carries risks, particularly with hemodynamic compromise.
Discussion:
- Adrenergic activation is crucial for supporting cardiovascular function during critical illness.
- The benefits of beta-blockers in chronic conditions may not translate to acute sepsis.
- Potential risks include exacerbating hemodynamic instability in septic patients.
Key Insights:
- The role of beta-blockers in sepsis is complex and requires careful consideration.
- Acute adrenergic support is vital for cardiovascular stability in sepsis.
- Existing evidence suggests caution is needed for beta-blocker therapy in septic patients.
Outlook:
- Further research is needed to clarify the precise role and safety of beta-blockers in sepsis.
- Future studies should carefully evaluate hemodynamic effects and patient outcomes.
- Developing nuanced treatment strategies for sepsis-induced myocardial dysfunction is essential.
Related Concept Videos
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...